Image
|
Figure Caption
Fig. S6
Lomitapide does not rescue the hematopoietic defect in apoc2 mutants. In situ hybridization with cmyb/runx1 and β-globin probes in WT, apoc2 mutants and the apoc2 mutants treated with 5 μM lomitapide. Lomitapide treatment was started at 2 dpf and continued until the embryos were fixed at 80 hpf for in situ hybridization. Scale bar, 200 μm.
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and
ZFIN has permission only to display this image to its users.
Additional permissions should be obtained from the applicable author or publisher of the image.
Full text @ Nat. Commun.